Predictive gene testing for Huntington disease and other neurodegenerative disorders

Internal Medicine Journal

Volumn 43, Issue 12, 2013, Pages 1272-1279

  Wedderburn, S ^a   Panegyres, P K ^a,b   Andrew, S ^a   Goldblatt, J ^c   Liebeck, T ^a   Mcgrath, F ^a   Wiltshire, M ^a   Pestell, C ^a   Lee, J ^a   Beilby, J ^d  

^a DEPARTMENT OF HEALTH   (Australia)

^b Neurodegenerative Disorders Research Pty Ltd   (Australia)

^c KING EDWARD MEMORIAL HOSPITAL   (Australia)

^d PATHWEST LABORATORY MEDICINE   (Australia)

Author keywords

Huntington disease; Neurodegenerative disorder; Predictive gene testing

Indexed keywords

ADOLESCENT; ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; DECISION MAKING; DEGENERATIVE DISEASE; DIAGNOSTIC TEST ACCURACY STUDY; FAMILIAL CREUTZFELDT JAKOB DISEASE; FAMILIAL DISEASE; FEMALE; GENETIC COUNSELING; GENETIC RISK; GENETIC SCREENING; HUMAN; HUNTINGTON CHOREA; MAJOR CLINICAL STUDY; MALE; PRACTICE GUIDELINE; PRENATAL DIAGNOSIS; PRION DISEASE; PRIORITY JOURNAL; PROTOCOL COMPLIANCE; PSYCHOLOGICAL ASPECT; RISK ASSESSMENT; SPINOCEREBELLAR DEGENERATION; SUICIDE;

HUNTINGTON DISEASE; NEURODEGENERATIVE DISORDER; PREDICTIVE GENE TESTING;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; DECISION MAKING; FEMALE; GENETIC TESTING; HUMANS; HUNTINGTON DISEASE; MALE; MIDDLE AGED; NEURODEGENERATIVE DISEASES; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; WESTERN AUSTRALIA; YOUNG ADULT;

EID: 84890241914     PISSN: 14440903     EISSN: 14455994     Source Type: Journal    
DOI: 10.1111/imj.12176     Document Type: Article

References (22)

1. Hayden MR. Predictive testing for Huntington's disease: the calm after the storm. Lancet 2000; 356: 1944-1945.
2. Tassicker RJ, Teltscher B, Trembath MK, Collins V, Sheffield LJ, Chiu E etal. Problems assessing uptake of Huntington disease predictive testing and a proposed solution. Eur J Hum Genet 2009; 17: 66-70.
3. Morrison PJ, Harding-Lester S, Bradley A. Uptake of Huntington disease predictive testing in a complete population. Clin Genet 2011; 80: 281-286.
4. Quaid KA, Swenson MM, Sims SL, Harrison JM, Moskowitz C, Stepanov N etal. What were you thinking?: Individuals at risk for Huntington disease talk about having children. J Genet Couns 2010; 19: 606-617.
5. Huntington Study Group. Unified Huntington's Disease Rating Scale: reliability and consistency. Mov Disord 1996; 11: 136-142.
6. World Federation of Neurology: Research Committee. Research Group on Huntington's chorea. Ethical issues policy statement on Huntington's disease molecular genetics predictive test. J Neurol Sci 1989; 94: 327-332.
7. Went L. Ethical issues policy statement on Huntington's disease molecular genetics predictive test. International Huntington Association. World Federation of Neurology. J Med Genet 1990; 27: 34-38.
8. International Huntington Association and the World Federation of Neurology Research Group on Huntington's Chorea. Guidelines for the molecular genetics predictive test in Huntington's disease. J Med Genet 1994; 31: 555-559.
9. Erez A, Plunkett K, Sutton VR, McGuire AL. The right to ignore genetic status of late onset genetic disease in the genomic era: prenatal testing for Huntington disease as a paradigm. Am J Med Genet 2010; 152A: 1774-1780.
10. Mariotti C, Ferruta A, Gellera C, Nespolo C, Fancellu R, Genitrini S etal. Predictive genetic tests in neurodegenerative disorders: a methodological approach integrating psychological counseling for at-risk individuals and referring clinicians. Eur Neurol 2010; 64: 33-41.
11. Panegyres PK, Goh JS, Goldblatt J. Codon 200 mutation in the prion gene: genotype - phenotype correlations. J Neurol 2012; 259: 2579-2584.
12. Trembath MK, Tassicker RJ, Collins VR, Mansie S, Sheffield LJ, Delatycki MB. Fifteen years of experience in predictive testing for Huntington disease at a single testing center in Victoria, Australia. Genet Med 2006; 8: 673-680.
13. Tassicker RJ, Marshall PK, Liebeck TA, Keville MA, Singaram BM, Richards FH. Predictive and pre-natal testing for Huntington disease in Australia: results and challenges encountered during a 10-year period (1994-2003). Clin Genet 2010; 70: 480-489.
14. Gargiulo M, Lejeune S, Tanguy ML, Lahlou-Laforet K, Faudet A, Cohen D etal. Long-term outcome of presymptomatic testing in Huntington disease. Eur J Hum Genet 2009; 17: 165-171.
15. Goizet C, Lesca G, Durr A, Group F. for Presymptomatic Testing in Neurogenetic Disorders. Presymptomatic testing in Huntington's disease and autosomal dominant cerebellar ataxias. Neurology 2002; 59: 1330-1336.
16. Almqvist EW, Block M, Brinkman R, Craufurd D, Hayden MR. A worldwide assessment of the frequency of suicide, suicide attempts, or psychiatric hospitalization after predictive testing for Huntington disease. Am J Hum Genet 1999; 64: 1293-1304.
17. Decruyenaere M, Evers-Kiebooms G, Cloostermans T, Boogaerts A, Demyttenaere K, Dom R etal. Psychological distress in the 5-year period after predictive testing for Huntington's disease. Eur J Hum Genet 2003; 11: 30-38.
18. Timman R, Roos R, Maat-Kievit A, Tibben A. Adverse effects of predictive testing for Huntington's disease underestimated: long-term effects 7-10 years after the test. Health Psychol 2004; 23: 189-197.
19. Wiggins S, Whyte P, Huggins M, Adam S, Theilmann J, Bloch M etal. The psychological consequences of predictive testing for Huntington's disease. Canadian collaborative study of predictive testing. N Engl J Med 1992; 327: 1401-1405.
20. Decruyenaere M, Evers-Kiebooms G, Cloostermans T, Boogaerts A, Demyttenaere K, Dom R etal. Predictive testing for Huntington's disease: relationship with partners after testing. Clin Genet 2004; 65: 24-31.
21. Licklederer C, Wolff G, Barth J. Mental health and quality of life after genetic testing for Huntington disease: a long-term effect study in Germany. Am J Med Genet A 2008; 146A: 2078-2085.
22. Tibben A. Predictive testing for Huntington's disease. Brain Res Bull 2007; 72: 165-171.